Single-cell sequencing maps immune changes in chronic myeloid leukemia
BCR
Compuscript Ltd Jul 9 2025 Chronic myeloid leukemia (CML) is a hematopoietic malignancy characterized by BCR-ABL1 gene fusion. The immune microenvironment, implicated in relapse and drug resistance, poses significant challenges towards CML treatment. Identifying immune microenvironment changes at the single-cell level may therefore aid in the development of personalized targeted therapies for CML. In a new study published in the Genes & Diseases journal, researchers from Huazhong Agricultural
din zilele anterioare